Humanin signal for Alzheimer's disease.
Matsuoka. Masaaki M
Key Findings
- Humanin can bind to a cell‑surface receptor and activate STAT3, helping prevent neuron death linked to Alzheimer’s.
- Neurons from Alzheimer’s patients show reduced Humanin signaling.
- Restoring or activating Humanin signaling might change the progression of Alzheimer’s disease.
Practical Outcomes
- For biohackers, the take‑away is that increasing Humanin could be a promising anti‑Alzheimer strategy, but there’s no proven supplement dose or method yet. Keep an eye on emerging research and consider lifestyle factors that might naturally raise Humanin levels, while awaiting clinical trials.
Summary
Humanin is a tiny protein that may protect brain cells from the damage that leads to Alzheimer’s disease. The study says that people with Alzheimer’s have lower levels of this protective signal, and boosting it could potentially slow or prevent the disease, but it doesn’t give a clear way to do that yet.
Abstract
Despite a bulk of evidence supporting the idea that increased neurotoxic insults lead to Alzheimer's disease (AD), the possibility still remains that insufficiency of an endogenous defense system contributes to the disease progression. Humanin is a bioactive peptide that is likely to inhibit both neuronal death and dysfunction only related to AD by binding to a Humanin receptor on the cell-surface and by activating a STAT3-mediated signal, preventing the onset of dementia. A couple of recent studies presented evidence suggesting that the Humanin signal is decreased in neurons of AD patients. If this is the case, the restoration or activation of the Humanin signal in neurons may change the course of AD.
Study Information
pubmed
2011
10.3233/jad-2011-102076